Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,571 | 64,326 | 75,973 | 198,270 | 248,009 |
| Marketable Securities | 27,851 | 108,671 | 162,212 | 141,239 | 165,052 |
| TOTAL | $115,228 | $178,778 | $244,291 | $347,554 | $419,802 |
| Non-Current Assets | |||||
| PPE Net | 3,821 | 10,252 | 12,985 | 14,880 | 13,646 |
| Investments And Advances | 0 | 1,989 | 9,762 | 0 | 49,001 |
| Other Non-Current Assets | 5,314 | 22,260 | 27,900 | 29,042 | 29,515 |
| TOTAL | $9,135 | $34,501 | $50,647 | $43,922 | $92,162 |
| Total Assets | $124,363 | $213,279 | $294,938 | $391,476 | $511,964 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,402 | 883 | 5,047 | 998 | 4,550 |
| Accrued Expenses | 7,617 | 11,335 | 12,963 | 9,063 | 4,974 |
| Other current liabilities | N/A | N/A | 1,129 | 1,456 | 2,395 |
| TOTAL | $15,277 | $24,695 | $21,486 | $13,626 | $12,856 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,864 | 9,584 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 21,506 | 25,379 | 28,953 | 32,753 | 33,589 |
| TOTAL | $21,506 | $29,506 | $28,953 | $32,753 | $33,589 |
| Total Liabilities | $36,783 | $54,201 | $50,439 | $46,379 | $46,445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,969 | 60,095 | 57,630 | 56,602 | 56,048 |
| Common Shares | 60 | 59 | 57 | 56 | 54 |
| Retained earnings | -594,940 | -508,861 | -396,188 | -262,984 | -111,906 |
| Other shareholders' equity | 9 | 19 | -792 | -39 | -19 |
| TOTAL | $87,580 | $159,078 | $244,499 | $345,097 | $465,519 |
| Total Liabilities And Equity | $124,363 | $213,279 | $294,938 | $391,476 | $511,964 |